Altered expression of norepinephrine transporter participate in hypertension and depression through regulated TNF-α and IL-6. (17th February 2020)
- Record Type:
- Journal Article
- Title:
- Altered expression of norepinephrine transporter participate in hypertension and depression through regulated TNF-α and IL-6. (17th February 2020)
- Main Title:
- Altered expression of norepinephrine transporter participate in hypertension and depression through regulated TNF-α and IL-6
- Authors:
- Meng, Lin
Bai, Xiaoxue
Zheng, Yan
Chen, Dongmei
Zheng, Yang - Abstract:
- ABSTRACT: Aim : We explored the role of histone modification in the association of depression-hypertension by comparing norepinephrine transporter ( NET ) gene levels in different depression-hypertensive patients. Then, we analyzed the expression of NET correlation with inflammatory cytokines to provide a new direction for detecting the association mechanism between depression and hypertension. Methods : NE expression levels in serum of diverse groups were detected by enzyme-linked immunosorbent assay. Then histone acetyltransferase (HAT), histone deacetylase (HDAC), H3K27ac, NET, TNF-α, and interleukin-6 ( IL-6 ) were detected by western blot in nine female subjects in different depression and hypertension groups, and Chromatin immunoprecipitation-polymerase chain reaction (Chip-PCR) were used to confirm the degree of acetylation affecting on the transcription level of NET gene. Meanwhile, correlation between NET with TNF/IL-6 was analyzed by SPSS19.0 software program. Finally, Quantitative real-time polymerase chain reaction (qPCR) and western blot were used to detect TNF-α and IL-6 expression levels after NET overexpression or interference treatment in human umbilical vein endothelial cells and Neuro-2a cells. Results : The expression of HAT and H3K27ac had lower levels in D-H and nonD-H group than nonD-nonH group. The results showed that higher acetylation could promote expression of NET genes. Meanwhile, the expression of NET had a significant negative correlation withABSTRACT: Aim : We explored the role of histone modification in the association of depression-hypertension by comparing norepinephrine transporter ( NET ) gene levels in different depression-hypertensive patients. Then, we analyzed the expression of NET correlation with inflammatory cytokines to provide a new direction for detecting the association mechanism between depression and hypertension. Methods : NE expression levels in serum of diverse groups were detected by enzyme-linked immunosorbent assay. Then histone acetyltransferase (HAT), histone deacetylase (HDAC), H3K27ac, NET, TNF-α, and interleukin-6 ( IL-6 ) were detected by western blot in nine female subjects in different depression and hypertension groups, and Chromatin immunoprecipitation-polymerase chain reaction (Chip-PCR) were used to confirm the degree of acetylation affecting on the transcription level of NET gene. Meanwhile, correlation between NET with TNF/IL-6 was analyzed by SPSS19.0 software program. Finally, Quantitative real-time polymerase chain reaction (qPCR) and western blot were used to detect TNF-α and IL-6 expression levels after NET overexpression or interference treatment in human umbilical vein endothelial cells and Neuro-2a cells. Results : The expression of HAT and H3K27ac had lower levels in D-H and nonD-H group than nonD-nonH group. The results showed that higher acetylation could promote expression of NET genes. Meanwhile, the expression of NET had a significant negative correlation with IL-6 ( R = −0.933, p < 0.01) and tumor necrosis factor ( TNF ) ( R = −0.817, p < 0.01) in subjects. In addition, the results confirmed that TNF-α and IL-6 mRNA and protein partial expressions could be inhibited by NET in both HUVECs and Neuronal cells ( p < 0.01). Conclusion : In conclusion, differential expression of NET gene might function as an important factor in interaction between depression and hypertension by partially targeting TNF-α and IL-6 . … (more)
- Is Part Of:
- Clinical and experimental hypertension. Volume 42:Number 2(2020)
- Journal:
- Clinical and experimental hypertension
- Issue:
- Volume 42:Number 2(2020)
- Issue Display:
- Volume 42, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 42
- Issue:
- 2
- Issue Sort Value:
- 2020-0042-0002-0000
- Page Start:
- 181
- Page End:
- 189
- Publication Date:
- 2020-02-17
- Subjects:
- NET -- depression -- hypertension -- histone acetylation -- TNF-α -- IL-6
Hypertension -- Chemotherapy -- Periodicals
Hypotensive agents -- Periodicals
616.132 - Journal URLs:
- http://informahealthcare.com/loi/ceh ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/10641963.2019.1601205 ↗
- Languages:
- English
- ISSNs:
- 1064-1963
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.250500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12537.xml